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Reference 1   GCCTGTCCTGCTTTCATCAGGTGGCTGGAAGAGTTCACCTCCCAGTACTCCAGGGATCAG TSS +261 
KOD-allele 1  GCCTGTCCTGCTTTCATCAGGTGGCTGGAAGAGTTCACCTCCCAGTAC-------ATCAG     -7nt 
KOD-allele 2  GCCTGTCCTGCTTTCATCAGGTGGCTGGAAGAGTTCACCTCCCAGT-------------G    -13nt 
 
Reference 1   GCCTGTCCTGCTTTCATCAGGTGGCTGGAAGAGTTCACCTCCCAGTACTCCAGGGATCAG TSS +261 
KOC-allele 1  GCCTGTCCTGCTTTCATCAGGTGGCTGGAAGAGTTCACCTCCCAGTACTTCCAGGGATCAG    +1bp 
KOC-allele 2  GCCTGTCCTGCTTTCATCAGGTGGCTGGAAGAGTTCACCTCCCAGTACCTCCAGGGATCAG    +1bp 
 
Reference 2   TGCTTCATGAACTCCCTGCTACAAGGCCTGTCTGCCTGTCCTGCTTTCATCAGGTGGCTG TSS +228          
KO11-allele 1 TGCTTCATGAACTCCCTGCTACAAGGCCTGTC--------CTGCTTTCATCAGGTGGCTG     -8bp 
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